A Randomized, Phase 2 Study Investigating TRV130, a Biased Ligand of the μ-opioid Receptor, for the Intravenous Treatment of Acute Pain | Cytel Resource Library

Author:

Viscusi, Eugene R.

Pain, 157, no. 1 264-272.
Viscusi, Eugene R., Bolognese, J., et al.

https://www.ncbi.nlm.nih.gov/pubmed/26683109

Interest:

Clinical Data Management